Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

FDA Clears InfraReDx Coronary Imaging System

BioPhotonics
Jun 2008
The FDA has granted 510(k) clearance to InfraReDx Inc. of Burlington, Mass., to market its catheter-based LipiScan coronary imaging system. The device uses near-infrared spectroscopy to identify lipid-core-containing plaques in the coronary arteries of patients undergoing cardiac catheterization. These plaques, which cannot be detected by commonly used tests, are suspected of causing sudden cardiac deaths and nonfatal heart attacks.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!